Roche coaches docs, RNs on diabetes care

Share this article:
Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetic patients and their caregivers.

Titled “Creative Coaching,” the program helps healthcare professionals with “the art of patient engagement,” said Luc Vierstraete, SVP and general manager of Roche's US diabetes unit, in a statement.

“What I appreciated most was the purpose of the weekend [program], which was to increase the quality of our healthcare,” said Linda Filipi, a California-based registered nurse, in the statement. “For us that means how to become better educators – for Roche, it is how to offer quality products.”

Roche manufactures the Accu-Chek line of blood glucose monitors. The professional education program, Behavior Change through Patient Engagement, is multifaceted and includes a website with online tools and information, as well as how to effectively integrate Accu-Chek products into their practice.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...